-
AI Startup ComplyCube Sees Staggering 500% Growth, Spurred by The Pandemic
Market news
prnewswireSeptember 13, 2021
LONDON, Sept. 3, 2021 /PRNewswire/ -- ComplyCube, the global Identity Verification (IDV) provider, has reported a growth of over 500% year-on-year, driven by a 20 times increase of biometric checks on its Software as a Service (SaaS) platform in H1 2021.
-
NeuExcell Therapeutics and Spark Therapeutics Announce Research Collaboration Agreement to Develop a Novel Gene Therapy for Huntington's Disease
Market news
prnasiaSeptember 13, 2021
OTCQX: RHHBY) today announced a gene therapy collaboration aimed at developing a safe and effective treatment for patients suffering from Huntington's Disease (HD).
-
JW Therapeutics Announces NMPA Approval of Relmacabtagene Autoleucel Injection in China
Market news
prnasiaSeptember 13, 2021
SHANGHAI, Sept. 6, 2021 /PRNewswire/ -- JW Therapeutics (HKEx: 2126), an innovative biotechnology company focused on developing, manufacturing and commercializing cell immunotherapy products
-
Major new study reveals that half of all people fear the internet and smartphones are damaging wellbeing
Market news
prnasiaSeptember 13, 2021
DHAHRAN, Saudi Arabia, Sept. 7, 2021 /PRNewswire/ -- As the world adjusts to a post-pandemic reality dominated by technology, public concerns about the dangers of over-consumption are gathering pace.
-
MIM Software Inc. Announces AI Segmentation and Single Timepoint Dosimetry Capabilities for Molecular Radiotherapy
Market news
prnasiaSeptember 13, 2021
CLEVELAND, Sept. 7, 2021 /PRNewswire/ -- MIM Software Inc., a leading global provider of medical imaging software, announced today new innovations to MIM SurePlan™ MRT, its software package for Molecular Radiotherapy.
-
Madison Street Capital Awarded "Distressed M&A Deal Of The Year" By The M&A Advisor's 15th Annual Turnaround Awards
Market news
prnewswireSeptember 13, 2021
AUSTIN, Texas, Sept. 7, 2021 /PRNewswire/ -- The M&A Advisor announced the recipients of its 15th Annual Turnaround Awards, recognizing those that reached the pinnacle of the distressed investing, bankruptcy, and restructuring industry over the past year.
-
New Study from StrategyR Highlights a $1.7 Billion Global Market for Biometric Sensors by 2026
Market news
prnewswireSeptember 13, 2021
SAN FRANCISCO, Sept. 7, 2021 /PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Biometric Sensors - Global Market Trajectory & Analytics".
-
Adlai Nortye Announces First Patient Dosed in Phase Ia Clinical Trial of AN2025 and AN0025 in Combination with atezolizumab for Advanced Solid Tumors
Market news
prnasiaSeptember 13, 2021
NORTH BRUNSWICK, New Jersey and HANGZHOU, China, Sept. 8, 2021 /PRNewswire/ -- Adlai Nortye, a global biopharmaceutical company focused on developing innovative oncology drugs...
-
Yiling Pharmaceutical's Yishen Yangxin Anshen Tablets Granted Drug Certificate
Market news
prnewswireSeptember 13, 2021
Yiling Pharmaceutical recently announced that its newly-developed drug Yishen Yangxin Anshen Tablet had been granted official drug certificate by China's National Medical Products Administration (NMPA).
-
NCCN Shares Latest Expert Recommendations for Prostate Cancer in Spanish and Portuguese
Market news
prnewswireSeptember 13, 2021
During Prostate Cancer Awareness Month the National Comprehensive Cancer Network is announcing up-to-date, translated guidelines featuring recent advances in care for one of the most-common types of cancer
LONDON, Sept. 3, 2021 /PRNewswire/ -- ComplyCube, the global Identity Verification (IDV) provider, has reported a growth of over 500% year-on-year, driven by a 20 times increase of biometric checks on its Software as a Service (SaaS) platform in H1 2021.
OTCQX: RHHBY) today announced a gene therapy collaboration aimed at developing a safe and effective treatment for patients suffering from Huntington's Disease (HD).
SHANGHAI, Sept. 6, 2021 /PRNewswire/ -- JW Therapeutics (HKEx: 2126), an innovative biotechnology company focused on developing, manufacturing and commercializing cell immunotherapy products
DHAHRAN, Saudi Arabia, Sept. 7, 2021 /PRNewswire/ -- As the world adjusts to a post-pandemic reality dominated by technology, public concerns about the dangers of over-consumption are gathering pace.
CLEVELAND, Sept. 7, 2021 /PRNewswire/ -- MIM Software Inc., a leading global provider of medical imaging software, announced today new innovations to MIM SurePlan™ MRT, its software package for Molecular Radiotherapy.
AUSTIN, Texas, Sept. 7, 2021 /PRNewswire/ -- The M&A Advisor announced the recipients of its 15th Annual Turnaround Awards, recognizing those that reached the pinnacle of the distressed investing, bankruptcy, and restructuring industry over the past year.
SAN FRANCISCO, Sept. 7, 2021 /PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Biometric Sensors - Global Market Trajectory & Analytics".
NORTH BRUNSWICK, New Jersey and HANGZHOU, China, Sept. 8, 2021 /PRNewswire/ -- Adlai Nortye, a global biopharmaceutical company focused on developing innovative oncology drugs...
Yiling Pharmaceutical recently announced that its newly-developed drug Yishen Yangxin Anshen Tablet had been granted official drug certificate by China's National Medical Products Administration (NMPA).
During Prostate Cancer Awareness Month the National Comprehensive Cancer Network is announcing up-to-date, translated guidelines featuring recent advances in care for one of the most-common types of cancer
Pharma Sources Insight 08/2021
